Over a 25 year period, 31 asthmatic children received artificial ventilation for acute asthma at Alder Hey Children's Hospital on 48 occasions. Altogether 47 episodes occurred from 1971-89, with no decline in the number of episodes per year (mean 2.5) over this period. Eight children died during intermittent positive pressure ventilation (IPPV), and of the 23 survivors, three further children had subsequently died from asthma. Seventeen children were followed up for more than a year after IPPV. Sixteen still had symptoms of asthma and over half had symptoms every day. Ten cooperated with pulmonary function tests: mean forced expiratory volume in one second was 83% of predicted and geometric mean provocative histamine concentration (PC20) was 2-1 mg/mi. Since the follow up study a fourth patient had died from asthma. IPPV continues to be required for a small number of asthmatic children each year. The survivors remain a high risk group with significant continuing morbidity and mortality.
Intermittent positive pressure ventilation (IPPV) using mechanical ventilators was developed during the 1950s and started to be used regularly to treat acute respiratory failure during the 1960s. The first paper to describe its use in asthmatic children reported a generally good outcome, ' and subsequent series, all from North America, have tended to show low mortality and complication rates.2" No sizable European series of IPPV in childhood asthma has been reported, the largest comprising six episodes.5 There has been no previous attempt to assess the subsequent outcome of children who survive IPPV for asthma. We report the experience of ventilating asthmatic children in a regional paediatric intensive care unit in a large children's hospital over a 25 year period. We describe the prior characteristics of children who required IPPV, the clinical course, and outcome of the episodes. Finally we document the subsequent outcome of children who survived the IPPV episodes.
Methods
Cases were found from the register of the Regional Paediatric Intensive Care Unit of Alder Hey Children's Hospital, which has been kept since the unit opened in 1964. Case notes were consulted of all admissions to the unit for whom asthma was recorded as one of the diagnoses. Only children who were ventilated for respiratory failure due to asthma were included in the study. This yielded 31 asthmatic children ventilated on 48 occasions between November 1964 and March 1989. The first part of the study was a retrospective survey of the characteristics of asthmatic children who required IPPV, the clinical course of the illness which led to respiratory failure, and the course and outcome of the IPPV episodes themselves. Details were extracted from the case notes by one investigator (PCS) using a proforma. If the child's regular care was in another hospital, the local hospital notes were reviewed also.
The second part was a follow up study of the children who had survived their episodes of IPPV for respiratory failure, excluding two children who were ventilated within 12 altered as the arterial pH before intubation had not changed significantly between the first 10 episodes (mean 7-10) and the last 10 episodes (7-11).
PATIENT CHARACTERISTICS
The age distribution (figure) was bimodal, with the main peak at 2 years of age, very few cases in the middle childhood years, and a smaller peak in the teens. This distribution is similar to that for childhood asthma deaths in Britain,9 but with the size of the peaks reversed. The male:female ratio was 1 2: 1. The median age of asthma onset was 1 year (range 5 months to 5 years).
Most of the children had a history of frequent admissions due to asthma. Twenty of 31 had been admitted more than twice in the preceding year, eight had only occasional admissions, and three children required IPPV on their first admission. Despite this, before their first IPPV episode more than half (17/31) were receiving bronchodilators alone or no treatment for their asthma. Seven were on sodium cromoglycate, four on inhaled steroids, and three on systemic steroids or adrenocorticotrophic hormone.
Number of IPPV episodes occumng at each age.
COURSE OF ATTACK BEFORE INTUBATION
The median recorded duration of the attack of asthma before admission was 10 hours (range 0-120); 33/48 were 24 hours or less. In most cases there was no clear precipitating event for the attack; one child required IPPV after an allergen challenge, and one developed bronchospasm during a general anaesthetic.
The median interval between admission and ventilation was seven hours; 38/48 episodes progressed to respiratory failure despite at least four hours of hospital treatment. Treatment received between admission and intubation included intravenous hydrocortisone in 40/48 episodes, intravenous aminophylline in 34, intravenous salbutamol in eight, nebulised salbutamol in 15, subcutaneous adrenaline in eight, and sedatives in eight. Changes in treatment evident over the years were the disappearance of subcutaneous adrenaline (last used in 1977) and of sedatives (1979) , and the appearance of intravenous (1975) and nebulised (1979) salbutamol. Surprisingly, since 1979 intravenous salbutamol had been used during only one episode, although high dose infusions have been shown capable of reversing respiratory failure in asthma.5 10 The decision to intubate was taken on a combination of clinical evidence and blood gases in 30 cases. For these episodes, the mean pH (SD) before intubation was 7 09 (0-1) and mean carbon dioxide tension (SD) was 116 (4 5) kPa. The rest had no blood gases recorded before intubation. One child was already intubated for a general anaesthetic and three were intubated on arrival at hospital after a respiratory arrest in home (n=2) or ambulance (n= 1). In the remaining 14 episodes the child progressed to respiratory failure in hospital, over a median time of six hours, without having blood gases recorded. By the time they were intubated, many children had developed evidence of cerebral or cardiac hypoxia. Two had a respiratory arrest in hospital and one a cardiac arrest during intubation. Six were semiconscious, five unconscious, and two having fits before intubation.
COURSE AND OUTCOME OF IPPV Median duration (range) of IPPV was three days (1-27). Volume cycled ventilators were used and all children received a muscle relaxant (turbocurarine chloride in 45/48 episodes) as well as sedation.
The commonest complications occurring during the 48 episodes were as follows. Lobar collapse occurred in 29 episodes (60%), and usually involved one or both upper lobes (28 episodes). Pneumomediastinum (leading to subcutaneous emphysema) was seen in 13 (27%) and pneumothorax in 10 (21%). Hypoxic-ischaemic encephalopathy developed during nine episodes, three of which had been preceded by cardiorespiratory arrest and one by hypoxic fits. None of the survivors suffered long term neurological sequelae. Transient proximal myopathy, which occurred in six episodes, has been reported previously after IPPV for asthma and is presumed to be due to steroids."1 Inappropriate antidiuretic hormone secretion (defined as hyponatraemia and fluid retention) occurred in six episodes, five of which were associated with hypoxic-ischaemic encephalopathy.
Eight of the 48 episodes (17%) had a fatal outcome. Cardiorespiratory arrest before IPPV, and hypoxic-ischaemic encephalopathy both predicted a poor prognosis. Five of six episodes preceded by a cardiorespiratory arrest were fatal, even though in three of the five fatal episodes the arrest occurred on the intensive care unit. Six of nine episodes complicated by hypoxic-ischaemic encephalopathy were fatal, and in five of these six there was evidence of cerebral hypoxia before intubation. Blood gases before intubation, where available, did not predict outcome, but those children intubated after an arrest had not usually had blood gases recorded. None of the other complications was statistically associated with a fatal outcome.
Multiple IPPV episodes were associated with a poor outcome: of the seven children ventilated more than once, five eventually died during an episode (p<005). Age also appeared to be a factor: the mean age at ventilation for fatal episodes (9-6 years) was significantly older than for non-fatal episodes (5 years) (p<0005). Children who had already received steroid treatment at home before their first IPPV episode were significantly more likely to die (p<0 05).
LONG TERM OUTCOME Eight of the 31 children had died during IPPV. Of the 23 survivors, three were found to have died subsequently, and one patient could not be traced. Of the 19 definite survivors, two had been ventilated less than 12 months before the follow up study. Only data from the 17 patients with at least 12 months' follow up will be presented.
Information from the general practitioner questionnaire was available for all 17 patients. One was said to be asymptomatic, nine (53%) had chronic daily symptoms, and seven had intermittent symptoms. Most patients were being prescribed prophylaxis: sodium cromoglycate in three cases and inhaled steroids in 10 (with additional theophylline in five). Three were only prescribed bronchodilators, but all three had chronic daily symptoms and clearly merited prophylaxis.
The personal questionnaire was completed for 15 patients. Nine of 15 (60%) experienced wheezing every day and two of these were constantly wheezy. Six (40%) awoke wheezing more than once a week and three were disturbed every night. Fourteen (93%) had more than 10 acute attacks per year, and five (33%) had missed two weeks of work or school due to asthma in the previous three months. Thirteen (87%) wheezed regularly on exercise.
All Ten patients attended for pulmonary function testing: their mean (SD) value as percent predicted for FEV, was 82-9 (12-9), for peak flow 98 8 (14 7), and for forced respiratory ratio 78-7 (9'5). Five had FEVy values less than 80% of predicted. Geometric mean provocative histamine concentration (PC20) was 2 1, range 0-23 to 32 mg/ml.
LATE DEATHS
The three children who died between the IPPV episode and follow up had all suffered from severe asthma since early childhood and were on long term systemic steroids. Since completing the study we have learnt of one more death (case 4). In all four cases the fatal incident was clinically a rapidly progressing asthma attack, though only one child (case 2) had a postmortem examination. This showed typical changes of acute on chronic severe asthma. The details of these four children are summarised in table 2.
In all, nine of the 28 children who survived 
